Kingdon Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-571,555
Closed -$4.19M 133
2016
Q3
$6M Sell
571,555
-273,745
-32% -$3.93M 0.27% 78
2016
Q2
$12.3M Buy
+845,300
New +$14.4M 0.68% 45
2015
Q3
Sell
-512,341
Closed -$12M 133
2015
Q2
$12M Buy
512,341
+277,341
+118% +$6.04M 0.47% 69
2015
Q1
$5.27M Buy
235,000
+130,564
+125% +$2.5M 0.22% 108
2014
Q4
$1.76M Sell
104,436
-2
-0% -$30 0.08% 132
2014
Q3
$1.49M Hold
104,438
0.07% 146
2014
Q2
$1.66M Sell
104,438
-90,000
-46% -$1.36M 0.06% 171
2014
Q1
$3.5M Sell
194,438
-187,061
-49% -$3.47M 0.18% 134
2013
Q4
$7.44M Buy
381,499
+200,000
+110% +$2.93M 0.34% 93
2013
Q3
$2.16M Hold
181,499
0.11% 158
2013
Q2
$1.98M Buy
+181,499
New +$3.82M 0.12% 166

Other funds holding DVAX

Kingdon Capital Management's DVAX Position: Q4 2016 in Review

Kingdon Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 571,555 shares — an estimated $4.19M sold.

Kingdon Capital Management first reported a position in DVAX in Q2 2013 and held it in 11 quarters. The position peaked at $12.3M in Q2 2016. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

  • Kingdon Capital Management reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
  • Kingdon Capital Management sold 571,555 Dynavax Technologies shares in Q4 2016, an estimated $4.19M.
  • Kingdon Capital Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 11 quarters.
  • Kingdon Capital Management's Dynavax Technologies position peaked at $12.3M in Q2 2016.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on Kingdon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.